EUVIMEDEUVIMED entdecken
Crossref

Clamp the LAMP: a photoelectrochemical platform for KRAS mutation detection via wild-type blocking

J Strmiskova, A Valverde, L Moranova, J Arnouts, F Zavadil-Kokas, S Koljenovic, K Zwaenepoel, T Vandamme, M Bartosik, K De Wael

Biosensors and Bioelectronics · 2026-07 · 304 · 118617

DOI: 10.1016/j.bios.2026.118617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-07. Verfasst von J Strmiskova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, 65653, Czech Republic; National Centre for Biomolec…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Biosensing Techniques, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek, Agentura Pro Zdravotnický Výzkum České Republiky, Grantová Agentura České Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

KRAS mutations are among the most prevalent oncogenic alterations in colorectal, lung and pancreatic cancer, yet their detection remains analytically challenging in the presence of an overwhelming wild-type (WT) background. Here, we report a photoelectrochemical (PEC) genotyping platform that integrates clamp-inhibited loop-mediated isothermal amplification (C-LAMP) with enzyme-free singlet oxygen (1O2)-driven PEC transduction for mutation-selective KRAS detection. Locked nucleic acid (LNA) clamp probes selectively suppress WT amplification during isothermal amplification, enriching mutant alleles and enabling single-nucleotide variant (SNV) discrimination with high selectivity. Amplified products are magnetically captured and transduced into photocurrent via visible-light-induced 1O2 redox cycling, eliminating enzymatic reporters and reducing background interference. The C-LAMP/PEC platform achieves a limit of detection of 35 copies μL-1 (58 aM) and a minimum detectable variant allele frequency (VAF) of 4.8% in heterogeneous mutant/WT genomic DNA mixtures. Analytical performance was validated in cancer cell lines and in patient-derived fresh frozen tissues, showing complete concordance with Nanopore sequencing and droplet digital PCR (ddPCR) within the evaluated cohort (n = 16). This work introduces a robust and modular PEC biosensing strategy that combines molecular WT suppression with enzyme-free photoelectrochemistry, offering an economically competitive and instrumentation-simplified approach for clinically relevant KRAS mutation analysis toward decentralized testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)Biosensing TechniquesNucleic Acid Amplification TechniquesHumansMutationElectrochemical TechniquesDNA Mutational AnalysisEquipment DesignLimit of DetectionCell Line, TumorOligonucleotides

Stichwörter der Autor:innen

Clamp-inhibited LAMPKRAS mutation detectionLocked nucleic acidsPhotoelectrochemical biosensingSinglet oxygenWild-type suppression

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanlocked nucleic acidOligonucleotides

Autor:innen und Institutionen

  • Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, 65653, Czech Republic; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Brno, 62500, Cz…
  • Antwerp Engineering, Photoelectrochemistry and Sensing (A-PECS), University of Antwerp, Antwerp, 2020, Belgium; NANOlight Centre of Excellence, University of Antwerp, Antwerp, 2020, Belgium.
  • Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, 65653, Czech Republic.
  • Department of Pathology, Antwerp University Hospital (UZA), Edegem, 2650, Belgium; Department of Oncology, Antwerp University Hospital (UZA), Edegem, 2650, Belgium; Centre for Oncological Research (CORE), University of…
  • Department of Pathology, Antwerp University Hospital (UZA), Edegem, 2650, Belgium; Centre for Oncological Research (CORE), University of Antwerp, Wilrijk, 2610, Belgium.
  • Department of Oncology, Antwerp University Hospital (UZA), Edegem, 2650, Belgium; Centre for Oncological Research (CORE), University of Antwerp, Wilrijk, 2610, Belgium.

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • Agentura Pro Zdravotnický Výzkum České Republiky
  • Grantová Agentura České Republiky
  • European Commission
  • Bijzonder Onderzoeksfonds UGent
  • Universiteit Antwerpen

Zitieren

APA

Strmiskova, J., Valverde, A., Moranova, L., Arnouts, J., Zavadil-Kokas, F., Koljenovic, S., Zwaenepoel, K., Vandamme, T., Bartosik, M., & De Wael, K. (2026). Clamp the LAMP: a photoelectrochemical platform for KRAS mutation detection via wild-type blocking. Biosensors and Bioelectronics, 304, 118617. https://doi.org/10.1016/j.bios.2026.118617

Vancouver

Strmiskova J, Valverde A, Moranova L, Arnouts J, Zavadil-Kokas F, Koljenovic S, et al. Clamp the LAMP: a photoelectrochemical platform for KRAS mutation detection via wild-type blocking. Biosensors and Bioelectronics. 2026;304:118617. doi:10.1016/j.bios.2026.118617

BibTeX
@article{Strmiskova2026,
  author = {Strmiskova, J and Valverde, A and Moranova, L and Arnouts, J and Zavadil-Kokas, F and Koljenovic, S and Zwaenepoel, K and Vandamme, T and Bartosik, M and De Wael, K},
  title = {Clamp the LAMP: a photoelectrochemical platform for KRAS mutation detection via wild-type blocking},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {304},
  pages = {118617},
  doi = {10.1016/j.bios.2026.118617}
}
Kostenlos starten →